Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 80

Results For "Oncology"

967 News Found

ACI Hospitals celebrates the spirit of women with their new campaign ‘WOWMOM’
Biotech | May 06, 2022

ACI Hospitals celebrates the spirit of women with their new campaign ‘WOWMOM’

The campaign aims to promote women’s health and wellness and urge them to visit the hospital for key medical check-ups


Sawai Man Singh Medical College (SMS), Jaipur collaborates with Intuitive India
Healthcare | May 05, 2022

Sawai Man Singh Medical College (SMS), Jaipur collaborates with Intuitive India

The workshop was organized by the Department of Urology as a first step to enabling government medical colleges in Rajasthan to offer the latest surgical technology


Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India
Biotech | May 04, 2022

Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India

Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication


Kokilaben Dhirubhai Ambani Hospital launches third da Vinci robotic surgical system
Hospitals | May 04, 2022

Kokilaben Dhirubhai Ambani Hospital launches third da Vinci robotic surgical system

It is the first hospital in the country to achieve the significant milestone of completing over 2600 robotic surgeries for treating patients with prostate, kidney and urinary bladder cancer


BeiGene to open new site at Princeton, New Jersey
Biotech | May 01, 2022

BeiGene to open new site at Princeton, New Jersey

Flagship U.S. facility will include biologic manufacturing and late stage research and clinical development of innovative cancer medicines


Sanofi continues to deliver strong business
News | April 28, 2022

Sanofi continues to deliver strong business

Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate


Enhertu granted Breakthrough Therapy Designation in the US for patients with HER2-low metastatic breast cancer
Biotech | April 27, 2022

Enhertu granted Breakthrough Therapy Designation in the US for patients with HER2-low metastatic breast cancer

Enhertu has now been granted five Breakthrough Therapy Designations, including three in breast cancer and one in both lung and gastric cancers


Tislelizumab plus chemo show promising results for esophageal cancer in Phase III study
Biotech | April 27, 2022

Tislelizumab plus chemo show promising results for esophageal cancer in Phase III study

Results support the development of tislelizumab in potentially synergistic combinations across Novartis advanced therapeutic platforms for the treatment of an array of solid tumours


CHMP adopts positive opinion on Tabrecta for advanced non-small cell lung cancer
Biotech | April 23, 2022

CHMP adopts positive opinion on Tabrecta for advanced non-small cell lung cancer

With one of the most diverse lung cancer development programs, Novartis is focused on investments to advance the science, drive treatment and make an impact on patients


Purigen launches ionic cells to pure DNA kit
Biotech | April 21, 2022

Purigen launches ionic cells to pure DNA kit

New kit enhances menu of FFPE solutions and allows oncology researchers to extract higher yields of concentrated DNA compared to traditional techniques